Polarean Imaging, founded with a mission to revolutionize lung diagnostics, designs and manufactures non-invasive helium and xenon imaging equipment. The company's core vision is to enhance the visibility of lung function without exposing patients to radiation. Polarean offers upgrade modules, measurement stations, helium cells, regulatory filling support, training, and repair services. Their market focus is primarily on healthcare providers in the United States, aiming to improve diagnostic accuracy and patient outcomes in respiratory medicine.
Notable figures affiliated with Polarean include leading scientists and industry experts in medical imaging and respiratory health. The company has attracted significant investment from venture capital firms specializing in biotechnology. Key achievements include the development of advanced xenon MRI technology, which allows for detailed regional lung function assessment in a single breath-hold. Polarean's impact is evident in its contribution to safer, more accurate lung diagnostics, potentially benefiting millions of patients with respiratory conditions.
